Have some news you want to share with the Oregon Bio community? Fill out our submission form.
Immunologist Michelle McMurry-Heath is Selected for Her Global Leadership and Commitment to Innovation and Patients
Former FDA Official Will Succeed Industry Leader Jim Greenwood on June 1 as Leader of World’s Largest Biotechnology Advocacy Association
May 14, 2020
WASHINGTON–(BUSINESS WIRE)–The Biotechnology Innovation Organization (BIO) – the world’s largest science and public advocacy organization, representing 1,000 members — announced today that Michelle McMurry-Heath, MD, PhD, will become the organization’s next President and CEO on June 1, succeeding former Rep. Jim […]
As we emerge from the pandemic, our Oregon and southwest Washington sectors of biotech, medical device, diagnostics and health IT are at the forefront of providing lifesaving and health-improving solutions like never before in history – from therapeutics to vaccines to testing to clinical trials to sterilization to PPE manufacturing to telehealth to tracing and tracking. A growth industry with high paying jobs, our bioscience industry answered the call and will continue to play a pivotal role in our region’s […]
FemTech innovator Madorra Medical is empowering women to live fuller, healthier lives. The Oprah Magazine featured the Oregon based company that is working towards changing the paradigm for treating vaginal dryness. Madorra provides a medical device solution to a problem that has previously only been served by pharmaceuticals. They are focused on giving post-menopausal women and breast cancer survivors the power to choose a non-hormonal treatment option. Learn more Here
This week, Business Oregon and the Oregon Innovation Council (Oregon InC) announced the Enhanced Innovation Grant Program that will fund up to five proposals from innovation-based companies that either show an ability to commercialize a technology that will help address the COVID-19 crisis and move to economic recovery or Oregon InC portfolio companies that are poised to commercialize their product.
Oregon InC supports companies with high-growth potential emerging from science and research. In 2018-2019, Oregon InC invested a total of $2,510,251 […]
Good Day Bio, April 28, 2020 – https://go.bio.org/index.php/email/emailWebview
Amidst the countless coronavirus headlines, you might have missed this news: changes to SEC rules just went into effect that will offer welcome relief for small biotech companies and help them deliver the new medicines we need. Here’s the scoop.
Catch me up! The Securities and Exchange Commission (SEC) adopted regulatory changes providing small public companies with a temporary exemption from compliance with Sarbanes-Oxley Act of 2002 Section 404(b), which requires public companies to […]
Oregon Bio welcomes new member HealthSaaS, the local powerhouse steering cognitive population health management through an ‘Internet of Things’ approach. And, it’s empowering a new standard of interactive and predictive healthcare through a new offering called CarePath AI.
And now, HealthSaas has teamed up with AkēLex and Hewlett Packard to employ those same tools to safely detect and track infectious conditions such as COVID-19. As a public service, HealthSaaS has developed a free, AI-powered screening tool, “COVID-19 Checkup” which […]
On April 16, federal administrators gave the green light to resume elective surgeries during their coronavirus briefing. The decision is part of the larger plan to gradually reopen the country as the coronavirus pandemic plays out.
AdvaMed President and CEO Scott Whitaker released the following statement, “We appreciate the President’s announcement tonight of a plan that would safely allow elective surgeries to resume. The term ‘elective surgeries’ implies they’re procedures patients choose to have, but in reality means surgeries or procedures that […]
Oregon Bio is pleased to provide members with the opportunity to apply to meet with Taiho Ventures, where select members looking to raise capital will join us for a series of one-on-one meetings, scheduled to take place virtually on Thursday, May 7th.
Taiho Ventures, LLC is the strategic corporate venture capital arm of Taiho Pharmaceutical Co., Ltd., a Japanese specialty pharma focusing on oncology, allergy and immunology, and urology. Taiho Ventures is looking at early-stage preclinical therapeutics companies as well as platform […]
Supported through a pediatric device consortia grant from the FDA, the West Coast Consortium for Technology & Innovation in Pediatrics (CTIP) is pleased to provide grants to support the advancement of innovations in pediatric technology and devices. Funds will be granted to develop pediatric innovation from ideation through commercialization. Funds are available to support the achievement of milestones on the path to development of pediatric innovation in devices and technology.
Up to seven grants will be awarded in the range of […]